Results 31 to 40 of about 5,026 (202)

Index of Body Inflammation for Maxillofacial Surgery Purpose-to Make the Soluble Urokinase-Type Plasminogen Activator Receptor Serum Level Independent on Patient Age

open access: yesApplied Sciences, 2021
Background: The serum suPAR level is affected in humans by it increases with age. Therefore it makes difficult interpretation and any comparison of age varied groups.
Marcin Kozakiewicz   +2 more
doaj   +1 more source

Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients

open access: yesScientific Reports, 2021
The prognostic significance of suPAR in various kidney diseases has recently been demonstrated. Its role in transplantation-specific outcomes is still largely unknown. Therefore, we prospectively investigated the prognostic relevance of suPAR in patients
Ulrich Jehn   +5 more
doaj   +1 more source

The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis [PDF]

open access: yes, 2012
It has been suggested that soluble urokinase plasminogen activator (suPAR) can be used as a marker of disease severity and risk of mortality in sepsis. The aim with the present study was to compare plasma levels of suPAR in patients with severe sepsis to
Bodelsson, Mikael   +12 more
core   +1 more source

suPAR to Risk-stratify Children with Malaria [PDF]

open access: yes, 2022
Severe malaria is a leading global cause of childhood morbidity and mortality, particularly in sub-Saharan Africa. However, current malaria diagnostic tests do not reliably identify children at risk of severe disease and death.
Stefanova, Veselina
core   +1 more source

The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia

open access: yesTurkish Journal of Hematology, 2016
INTRODUCTION: The soluble urokinase plasminogen activator receptor (suPAR) is a soluble form of the urokinase plasminogen activator receptor expressed in various immune and cancer cells.
Nergiz Erkut   +6 more
doaj   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation

open access: yesFrontiers in Immunology, 2021
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation that plays a major role in immunosenescence and in development and progression of many diseases.
Line Jee Hartmann Rasmussen   +3 more
doaj   +1 more source

A soluble form of the urokinase plasminogen activator receptor (suPAR) can bind to hematopoietic cells [PDF]

open access: yes, 1998
The receptor for urokinase plasminogen activator (uPAR; CD87) is a 50‐ to 65‐kDa glycosylphosphatidylinositol (GPI)‐anchored glycoprotein expressed by leukocytes and tumor cells where it facilitates uPA‐dependent, plasmin‐mediated pericellular ...
Mizukami, Ikuko F.   +3 more
core   +1 more source

Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population

open access: yesBiomarker Insights, 2014
The soluble urokinase plasminogen activator receptor (suPAR) is a biomarker of mortality risk in various patient populations. However, little is known about the implications of lifestyle for suPAR levels in the general population. Lifestyle, demographic,
Thomas H. Haupt   +7 more
doaj   +1 more source

Soluble urokinase plasminogen activator receptor: a novel biomarker of pediatric community-acquired and hospitalacquired pneumonia

open access: yesThe Turkish Journal of Pediatrics, 2022
Background. Soluble urokinase plasminogen activator receptor (suPAR) is an emerging biomarker in different clinical disorders but data in pediatric pneumonia is scarce.
Muhammad Said El-Mekkawy   +2 more
doaj   +1 more source

Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department

open access: yesJournal of Family Medicine and Primary Care, 2019
Background: *Soluble urokinase-type plasminogen activator receptor (suPAR) is a new biomarker, which is increased in conditions associated with inflammatory immune cell activation. In low resource, densely populated countries, there is a need for a quick
Pratyush Kumar   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy